Jessica Spinelli to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Jessica Spinelli has written about Xenograft Model Antitumor Assays.
Connection Strength
0.087
-
Yu JX, Suh JM, Popova KD, Garcia K, Joshi T, Culbertson B, Spinelli JB, Subramanyam V, Lou K, Charbonneau T, Shokat KM, Weissman J, Goodarzi H. The GENEVA platform models tumor mosaicism to reveal variations of responses to KRAS inhibitors and identify improved drug combinations. Nat Cancer. 2026 Mar; 7(3):522-537.
Score: 0.057
-
Brown KK, Spinelli JB, Asara JM, Toker A. Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer. Cancer Discov. 2017 04; 7(4):391-399.
Score: 0.030